198 related articles for article (PubMed ID: 9770714)
21.
Zhao L; Zhang W; Xin Y; Wen Q; Bail L; Guan F; Bin J
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):349-353. PubMed ID: 30413358
[TBL] [Abstract][Full Text] [Related]
22. Improved dose concept for radioiodine therapy of multifocal and disseminated functional thyroid autonomy.
Reinhardt M; Emrich D; Krause T; Bräutigam P; Nitzsche E; Blattmann H; Schümichen C; Moser E
Eur J Endocrinol; 1995 May; 132(5):550-6. PubMed ID: 7749494
[TBL] [Abstract][Full Text] [Related]
23. 99Tc(m)-MIBI scanning of the thyroid gland in patients with markedly decreased pertechnetate uptake.
Alonso O; Mut F; Lago G; Aznarez A; Núñez M; Cánepa J; Touya E
Nucl Med Commun; 1998 Mar; 19(3):257-61. PubMed ID: 9625501
[TBL] [Abstract][Full Text] [Related]
24. The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound.
Meller J; Becker W
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S425-38. PubMed ID: 12192542
[TBL] [Abstract][Full Text] [Related]
25. Small thyroid volumes and normal iodine excretion in Berlin schoolchildren indicate full normalization of iodine supply.
Liesenkötter KP; Kiebler A; Stach B; Willgerodt H; Grüters A
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 4():46-50. PubMed ID: 9439915
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of (99m)Tc-pertechnetate thyroid scintigraphy in radioiodine therapy in a cohort of Chinese Graves' disease patients: a pilot clinical study.
Hou H; Hu S; Fan R; Sun W; Zhang X; Tian M
Biomed Res Int; 2015; 2015():974689. PubMed ID: 25879041
[TBL] [Abstract][Full Text] [Related]
27. [Prediction of remission in Graves' disease after thionamide therapy by technetium-99m early uptake].
Misaki T; Dokoh S; Koh T; Shimbo S; Hidaka A; Iida Y; Kasagi K; Konishi J
Kaku Igaku; 1991 Feb; 28(2):157-61. PubMed ID: 1711131
[TBL] [Abstract][Full Text] [Related]
28. Pertechnetate thyroid uptake is not always suppressed in patients with subacute thyroiditis.
Shigemasa C; Teshima S; Taniguchi S; Ueta Y; Mitani Y; Yoshida A
Clin Nucl Med; 1997 Feb; 22(2):109-14. PubMed ID: 9031769
[TBL] [Abstract][Full Text] [Related]
29. [Interference factors in the in vivo diagnosis of the thyroid].
Anger K; Funke G; Lagemann K
Nuklearmedizin; 1985 Feb; 24(1):7-11. PubMed ID: 2582373
[TBL] [Abstract][Full Text] [Related]
30. [Concept and validation of a simple model of the intrathyroidal iodine kinetics].
Rink T; Bormuth FJ; Braun S; Zimny M; Schroth HJ
Nuklearmedizin; 2004 Feb; 43(1):21-5. PubMed ID: 14978537
[TBL] [Abstract][Full Text] [Related]
31. Separation of autonomous function from cell density in non-immunogenic hyperthyroidism. I. Quantification by double-isotope parametric scintigraphy.
Als C; Listevnik M; Rösler H; Ritter EP
Nuklearmedizin; 1995 Dec; 34(6):215-22. PubMed ID: 8596737
[TBL] [Abstract][Full Text] [Related]
32. Uninhibited thyroidal uptake of radioiodine despite iodine excess in amiodarone-induced hypothyroidism.
Wiersinga WM; Touber JL; Trip MD; van Royen EA
J Clin Endocrinol Metab; 1986 Aug; 63(2):485-91. PubMed ID: 3013921
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the factors associated with Tc-99m pertechnetate uptake in thyrotoxicosis and graves' disease.
Kidokoro-Kunii Y; Emoto N; Cho K; Oikawa S
J Nippon Med Sch; 2006 Feb; 73(1):10-7. PubMed ID: 16538017
[TBL] [Abstract][Full Text] [Related]
34. Low thyrotropin (TSH) levels in goiter. Relationship with scintigraphic findings and other biological parameters.
Talbot JN; Duron F; Piketty ML; Habert MO; Laforest MD; Milhaud G
Thyroidology; 1989 Apr; 1(1):39-44. PubMed ID: 2484906
[TBL] [Abstract][Full Text] [Related]
35. Thyrotoxic Graves' disease with normal thyroidal technetium-99m pertechnetate uptake.
Ikekubo K; Hino M; Ito H; Koh T; Ishihara T; Kurahachi H; Kasagi K; Hidaka A; Mori T
Ann Nucl Med; 1990 Jul; 4(2):43-8. PubMed ID: 2171608
[TBL] [Abstract][Full Text] [Related]
36. Incidence of a pyramidal lobe on thyroid scans.
Levy HA; Sziklas JJ; Rosenberg RJ; Spencer RP
Clin Nucl Med; 1982 Dec; 7(12):560-1. PubMed ID: 6293751
[TBL] [Abstract][Full Text] [Related]
37. Is thyroid scintigraphy necessary before I-131 therapy for hyperthyroidism? Concise communication.
Ripley SD; Freitas JE; Nagle CE
J Nucl Med; 1984 Jun; 25(6):664-7. PubMed ID: 6327946
[TBL] [Abstract][Full Text] [Related]
38. Quantitative thyroid fluorescent scanning: technique and clinical experience.
Thrall JH; Gillen MT; Johnson MC; Corcoran RJ; Wartofsky L
AJR Am J Roentgenol; 1978 Mar; 130(3):517-22. PubMed ID: 415561
[TBL] [Abstract][Full Text] [Related]
39. [Thyroid gland hemiagenesis with Graves' disease].
Mikosch P; Gallowitsch HJ; Kresnik E; Lind P
Nuklearmedizin; 1999; 38(1):35-7. PubMed ID: 9987780
[TBL] [Abstract][Full Text] [Related]
40. Comparison of urinary iodine excretion and thyroid volume in students with or without constant iodized salt intake.
Gärtner R; Bechtner G; Rafferzeder M; Greil W
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 4():43-5. PubMed ID: 9439914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
